The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2

Clinical trial NCT00279058 · COMPLETED

Trial details

NCT number: NCT00279058
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2005-12-01
Primary completion: 2008-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.